NMN vs NR (Nicotinamide Riboside): Which NAD+ Precursor Is Better?

NMN (nicotinamide mononucleotide) is the direct precursor to NAD+, one enzymatic step away, while NR (nicotinamide riboside) is two steps away, and human trials show both raise blood NAD+ when taken orally with no large head-to-head study proving either one superior. NR has the larger published human trial record, including Martens et al. (2018) in Nature Communications, while NMN’s strongest human result is a 2021 Science trial by Yoshino and colleagues in which 250 mg daily improved muscle insulin sensitivity.

If you’ve started researching NAD+ supplementation, you’ve almost certainly run into the NMN vs. NR debate. Both are precursors to NAD+, the coenzyme your cells need for energy production, DNA repair, and dozens of other critical functions. Both raise NAD+ levels when taken orally. And both have vocal advocates in the longevity research community.

But they’re not identical. They enter the NAD+ biosynthesis pathway at different points, they have different bodies of clinical evidence, and they come with different price tags. The question isn’t really “which one is better” in absolute terms. The question is which one makes more sense for you, given the current state of the science and your individual priorities.

Is NMN a Precursor to NAD+?

Yes. NMN, also written beta-NMN, is the immediate precursor to NAD+ (nicotinamide adenine dinucleotide): the enzyme NMNAT attaches an adenylyl group from ATP to NMN and produces NAD+ in a single step. NR sits one step further back, because the kinases NRK1 and NRK2 must first add a phosphate to turn NR into NMN.

Both molecules belong to the vitamin B3 family. Cells also build NAD+ from nicotinamide through the enzyme NAMPT, which makes NMN, from nicotinic acid (niacin) through the Preiss-Handler pathway, and from the amino acid tryptophan through the de novo pathway. Most NAD+ is recycled through the nicotinamide salvage pathway, which places NMN at a central junction.

For how NMN and NR fit alongside niacin, nicotinamide and other options, see our overview of NAD+ supplements, including NMN and NR.

The Biosynthesis Pathway: Where Each One Enters

To understand the NMN vs. NR debate, you need a simplified picture of how your body makes NAD+.

NAD+ can be synthesized from several precursor molecules through different pathways. The two that matter here are:

The NR pathway: NR is taken up by cells and converted to NMN by enzymes called NRK1 and NRK2 (nicotinamide riboside kinases). That NMN is then converted to NAD+ by the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase).

The NMN pathway: NMN can potentially enter cells directly (more on this below) and is converted to NAD+ by NMNAT in a single step.

So the key difference: NR requires two enzymatic conversions to become NAD+, while NMN requires only one. On paper, this seems like an advantage for NMN. In practice, the NRK1 step converting NR to NMN is fast and efficient, so the extra step may not be a meaningful bottleneck.

The Scientific Camps: Sinclair vs. Brenner

Much of the public NMN vs. NR debate traces back to two prominent researchers with different perspectives.

The Sinclair Camp (NMN)

Dr. David Sinclair, a professor of genetics at Harvard Medical School, has been the most visible advocate for NMN. His lab has published influential mouse studies in which NMN improved age-related declines in blood vessel function, exercise capacity, and metabolic health. Sinclair has publicly stated that he takes NMN himself as part of his personal longevity regimen.

Sinclair’s research emphasizes NAD+’s role in activating sirtuins, a family of proteins that regulate aging, inflammation, and stress resistance. His framing is that NMN is a more direct route to NAD+ because it’s only one step away, and that the discovery of a dedicated NMN transporter (Slc12a8) supports the idea that the body has evolved mechanisms to use NMN directly.

The Brenner Camp (NR)

Dr. Charles Brenner, currently at City of Hope National Medical Center, discovered NR as a vitamin and NAD+ precursor in 2004. His work established the NRK pathway and demonstrated that NR could boost NAD+ in yeast, mice, and humans. He has worked as a scientific adviser to ChromaDex, the company that makes Niagen (the patented, commercially available form of NR).

Brenner has argued that NR has a more established evidence base, with more completed human clinical trials. He has also raised questions about NMN’s absorption, noting that in some contexts NMN may need to be converted to NR before it can enter cells, which would make NMN essentially a prodrug of NR.

What does David Sinclair say about NMN vs NR?

David Sinclair favors NMN and has said publicly that he takes it, while Charles Brenner favors NR, which his lab first described as an NAD+ precursor. Sinclair’s case rests on NMN being one step from NAD+ and on the Slc12a8 transporter study by Grozio et al. (2019). Most of the Sinclair lab’s NMN data comes from mice, while Brenner’s case rests on NR’s larger human trial record.

Both researchers have commercial ties to companies in the NAD+ field. Their public positions are most useful when read alongside the human trial results below, not in place of them.

The Slc12a8 Transporter Question

This is one of the most debated points in the field. In 2019, a study from Shin-ichiro Imai’s lab (a collaborator of Sinclair’s) identified a protein called Slc12a8 that appeared to transport NMN directly into gut cells in mice. If true, this would mean NMN doesn’t need to be converted to NR for cellular uptake.

The finding was significant but also controversial. Some researchers questioned the methodology and whether Slc12a8 truly functions as a dedicated NMN transporter in vivo, particularly in humans. The debate hasn’t been fully resolved, but subsequent research has largely confirmed that oral NMN supplementation does increase NAD+ levels in human blood and tissues, whether the mechanism involves direct transport, conversion to NR and re-synthesis, or both.

From a practical standpoint, both NMN and NR raise NAD+ in humans. The exact cellular entry mechanism matters for biochemistry but may not change your supplement decision.

Clinical Evidence: What Human Trials Show

Human trials of NMN and NR are small and short, usually a few dozen participants followed for 6 to 12 weeks. They consistently show that both precursors raise NAD+ in blood. Evidence that either one changes hard clinical outcomes, such as disease rates or lifespan, does not yet exist in humans.

NR Human Trials

NR, particularly as Niagen, has the larger published clinical trial portfolio. Key findings include:

• NAD+ elevation: Multiple studies confirm NR at 300 to 1,000 mg daily increases whole blood NAD+ by 40 to 90% within 2 to 4 weeks.
• Cardiovascular: A trial in healthy older adults showed NR reduced systolic blood pressure by about 5 mmHg and improved aortic stiffness, a marker of vascular aging.
• Parkinson’s disease: The NADPARK trial showed NR increased brain NAD+ (measured by MRS imaging) and was associated with mild clinical improvements in a subset of patients.
• Skeletal muscle: NR augmented the NAD+ metabolome in aged human skeletal muscle and induced anti-inflammatory gene expression changes.
• Safety: Across all published trials, NR has shown a favorable safety profile with no serious adverse events attributable to the supplement.

The blood pressure and aortic stiffness signals come from Martens et al. (2018), a pilot crossover trial that was not powered to confirm them, so they point to what larger trials should test rather than settle the question.

NMN Human Trials

NMN’s human trial data started appearing later but is accumulating quickly. Key findings:

• NAD+ elevation: Oral NMN at 250 to 1,250 mg daily raises NAD+ metabolites in blood, with a dose-response relationship.
• Insulin sensitivity: A Science paper showed 250 mg NMN daily improved muscle insulin sensitivity in postmenopausal prediabetic women, an important finding given the link between NAD+ decline and metabolic dysfunction.
• Aerobic capacity: A study in amateur runners showed NMN supplementation improved aerobic capacity during exercise training.
• Sleep quality: One trial suggested NMN may reduce drowsiness and improve physical performance in older adults.
• Muscle function in older men: Igarashi et al. (2022) reported that 250 mg of NMN daily for 12 weeks raised blood NAD+ and changed some measures of muscle function in healthy older men.
• Safety: Published trials show NMN is well-tolerated at doses up to 1,250 mg daily, with no serious adverse events.

Has NMN been compared directly with NR?

No large randomized trial has given NMN to one group and NR to another and compared the results. Every comparison on this page is indirect: it sets NMN trials beside NR trials that used different doses, populations and lab methods. Claims that one precursor is clearly superior go beyond what the human data currently shows.

Side-by-Side Comparison

NMN is one step from NAD+ and NR is two steps away, NR has more completed human trials, and both raise blood NAD+ by broadly similar amounts in published studies. The table sets out the main attributes of each precursor.

Bioavailability: Does the Delivery Method Matter?

Yes. How you take these supplements affects how much active compound reaches your bloodstream.

Standard oral capsules: Both NMN and NR are absorbed through the gut. First-pass metabolism in the liver processes a portion of the dose before it reaches systemic circulation. This is the most common delivery method and the one used in most clinical trials.

Sublingual NMN: Some NMN products are designed to dissolve under the tongue, allowing absorption through the sublingual mucosa directly into the bloodstream. This bypasses first-pass liver metabolism and may increase bioavailability. A few pharmacokinetic studies suggest sublingual NMN produces faster and higher peak blood levels than swallowed capsules, though head-to-head comparative trials are limited.

Enteric-coated NMN: These formulations protect NMN from stomach acid degradation and release it in the small intestine. Whether this meaningfully improves absorption compared to standard capsules is debated.

Liposomal formulations: Both NMN and NR are available in liposomal forms, where the active compound is encapsulated in lipid bubbles that may improve absorption and cellular uptake. The evidence for superior bioavailability is mostly from in vitro studies and marketing materials rather than rigorous human comparisons.

Intravenous NAD+: Some clinics skip the precursors and infuse NAD+ itself, a cash pay service covered in the section on NAD+ IV therapy below. Human research on oral NMN and NR is currently larger than the controlled research on NAD+ infusions.

Combination Strategies

Many NAD+ supplement users combine their precursor with other compounds. The two most common pairings:

TMG (Trimethylglycine) with NMN

When your body converts NMN (or NR) to NAD+, it eventually produces nicotinamide as a metabolic byproduct. Clearing nicotinamide requires methylation, a biochemical process that consumes methyl donors. If you’re taking high-dose NMN daily, there’s a theoretical concern about depleting your body’s methyl donor pool over time.

TMG (also called betaine) is a potent methyl donor. Some users take 500 to 1,000 mg of TMG alongside NMN to supply methyl groups for processing the extra nicotinamide. This is a precautionary strategy based on biochemical logic, not on a clinical trial showing it is necessary. TMG is inexpensive and generally well tolerated.

Resveratrol with NMN

David Sinclair has proposed that resveratrol activates sirtuins (the “accelerator”) while NAD+ provides the fuel sirtuins need to function. His lab’s animal data supports this synergy. Whether the combination produces clinically meaningful benefits in humans beyond what either compound does alone hasn’t been definitively demonstrated, but many longevity enthusiasts follow this stack.

If you take resveratrol, consume it with a fat-containing meal. Resveratrol is fat-soluble and has very poor bioavailability without dietary fat to aid absorption.

Urolithin A with an NAD+ precursor

A newer, less common pairing combines an NAD+ precursor with Urolithin A, a gut-derived metabolite that triggers mitophagy, the cellular cleanup of damaged mitochondria. The rationale is complementary: NAD+ precursors support mitochondrial energy production while Urolithin A helps clear worn-out mitochondria. Urolithin A is one of the few longevity compounds with multiple randomized human trials behind it, though the two have not been formally tested together.

Price Comparison Per Effective Dose

Cost matters, especially for a supplement you plan to take daily for years. Here’s how the math works out for commonly used products:

On a pure cost-per-milligram basis, bulk NMN powders tend to be cheaper than branded NR capsules. But cost per milligram isn’t the only factor. The quality of the evidence, the reliability of third-party testing, and the consistency of manufacturing also matter.

Prices change often and differ by retailer, so treat the figures above as a snapshot rather than a quote. Products are listed to show how cost per milligram is calculated, not as recommendations.

So Which Should You Choose?

Here’s the honest answer: both work, and the best choice depends on what you value most.

Choose NR if:

• You prioritize the volume of published human clinical data.
• You want the branded form of NR (Niagen) that was used in most published NR trials.
• You prefer a molecule with a longer track record in human studies.
• Simplicity matters to you (one capsule, well-established dose, no need for companion supplements).

Choose NMN if:

• You’re drawn to the one-step conversion advantage and the emerging Slc12a8 transporter data.
• You want more flexibility in brands, forms (sublingual, powder, capsule), and dosing.
• You follow the Sinclair research and want to align with that protocol.
• You prefer the slightly lower cost per milligram that bulk NMN offers.

The truth is, the NMN vs. NR debate generates more heat than the underlying science warrants. Both molecules end up in the same place (NAD+), both raise NAD+ levels reliably in humans, and both have acceptable safety profiles. Consistency of daily use matters more than which precursor you pick. Choose one, take it regularly, and reassess in a few months based on how you feel and, if you have access, blood NAD+ testing.

For typical oral and IV amounts, see our guide to NAD+ dosage.

NMN and NR vs NAD+ IV Therapy

NAD+ IV therapy delivers NAD+ itself through a vein instead of relying on an oral precursor such as NMN or NR. Infusions are given in clinics, usually under the oversight of a physician, nurse practitioner or registered nurse, and often in integrative, functional medicine or IV hydration practices. NAD+ infusions are cash pay and are not FDA approved for aging, fatigue or any other use.

Clinics often offer NAD+ infusions to people dealing with fatigue, long COVID or chronic fatigue syndrome. Controlled human evidence for those uses is thin, and much less developed than the oral NMN and NR trial record described above. Our guide to NAD+ IV therapy, how it works and what the evidence shows covers the treatment in more detail, and NAD+ IV vs oral supplements compares the two routes.

If you decide to explore infusions, you can compare NAD+ IV therapy clinics across the US in the Regenerated.com directory. The directory is free for patients, listing order is not paid ranking, Featured slots are labeled and capped, and Verified means a clinic completed credential checks, not that it paid. Inclusion in the directory is not an endorsement, so ask each clinic who supervises infusions and how they screen patients.

Frequently Asked Questions

Does NMN or NR raise NAD+ levels more effectively?

Neither NMN nor NR has been shown to raise NAD+ more effectively, because no large trial has compared them directly. In separate human trials, oral NR raised blood NAD+ by about 40 to 90 percent and oral NMN by about 40 to 80 percent within weeks, with higher doses giving larger increases. NMN reaches NAD+ in one enzymatic step and NR in two, but the extra NRK1 step is fast and does not appear to be a meaningful bottleneck.

How much do NMN and NR cost per month?

NMN and NR cost roughly the same per month, but bulk NMN is usually cheaper per milligram. Based on the product prices listed above, NR as Tru Niagen runs about $40 to $94 a month at 300 to 600 mg daily, and NMN runs about $45 to $60 a month at 500 to 1,000 mg daily. Cost per milligram ranges from about $0.06 to $0.18 depending on product and form, and prices change often.

What daily doses have been studied for NMN and NR?

Human trials have tested NR at 300 to 1,000 mg daily and NMN at 250 to 1,250 mg daily, and both raised blood NAD+ with a dose-response relationship. The 2021 Science trial of NMN used 250 mg a day for 10 weeks, and Martens et al. (2018) used 1,000 mg of NR a day in healthy middle-aged and older adults. Most trials lasted weeks to a few months, so long term dosing data is limited.

Is one safer than the other, and what about side effects?

Neither NMN nor NR has shown a clear safety advantage: both were well tolerated in published human trials, with no serious adverse events attributed to the supplement. The most commonly reported complaints are mild digestive symptoms. People with active cancer should speak with their oncologist before taking either one, and there is not enough safety data to support use during pregnancy or breastfeeding. Most trials were short, so long term safety is less well studied.

What health benefits has each shown in human trials?

NR and NMN have each shown early, specific benefits in small human trials. NR lowered systolic blood pressure by about 5 mmHg and improved aortic stiffness in a pilot trial, and raised brain NAD+ in the NADPARK Parkinson’s disease trial. NMN improved muscle insulin sensitivity in prediabetic women and aerobic capacity in amateur runners. NR has more published human trials (10 or more) than NMN (5 or more), and none of these findings has been confirmed in large outcome trials.

Which one should I choose, NMN or NR?

Both NMN and NR raise NAD+, so the better choice depends on what you value most. NR suits people who want the larger body of published human trials and a longer track record. NMN suits people drawn to its one-step conversion to NAD+, the wider range of forms, or its slightly lower cost per milligram. Taking either one consistently matters more than which precursor you pick, and a clinician can help if you take other medications.

Sources

1. Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002
2. Grozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019;1(1):47-57. doi:10.1038/s42255-018-0009-4
3. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985
4. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7
5. Brakedal B, Dolle C, Riber F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab. 2022;34(3):396-407. doi:10.1016/j.cmet.2022.02.001
6. Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728. doi:10.1016/j.celrep.2019.07.043
7. Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. doi:10.1186/s12970-021-00442-4
8. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. doi:10.1038/s41514-022-00084-z
9. NAD+ IV Therapy: The Complete Guide
10. Best NAD+ Supplements: NMN, NR, Niacin, and How to Choose
11. IV Therapy: Benefits, Risks, and What the Science Says
12. Regenerative Medicine and Longevity